Identification |
Name: | 6-Quinoxalinamine,5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)- |
Synonyms: | 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline;AGN 190342;Bromoxidine;UK 14304-18;5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine;5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine;6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-; |
CAS: | 59803-98-4 |
Molecular Formula: | C11H10BrN5 |
Molecular Weight: | 292.13 |
InChI: | InChI=1/C11H10BrN5/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8/h1-4H,5-6H2,(H2,15,16,17) |
Molecular Structure: |
|
Properties |
Transport: | UN 2811 |
Flash Point: | 215.4 ºC |
Boiling Point: | 432.6 ºC |
Density: | 1.82 g/cm3 |
Stability: | Stable at normal temperatures and pressures. |
Refractive index: | 1.798 |
Appearance: | Yellow Solid |
Specification: |
?Brimonidine (59803-98-4) also can be called 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine ; Brom-N-(4,5-dihydro-1H-imidazol-2-yl)chinoxalin-6-amin ; 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine ; 5-Bromo-6-(imidazolin-2-ylamino)quinoxaline .
|
Packinggroup: | III |
Flash Point: | 215.4 ºC |
Storage Temperature: | Keep container tightly closed. |
Usage: | a2-Adrenoceptor agonist. Antiglaucoma |
Safety Data |
Hazard Symbols |
T:Toxic
|
|
|